Antimicrobial resistance in Campylobacter: Susceptibility testing methods and resistance trends

Journal of Microbiological Methods

Volumn 95, Issue 1, 2013, Pages 57-67

  Ge, Beilei ^a   Wang, Fei ^a,b   Sjölund Karlsson, Maria ^c   McDermott, Patrick F ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

Antimicrobial resistance; Campylobacter; Molecular; Susceptibility testing; Trend

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFALOTIN; CEFOTAXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; FLORFENICOL; GENTAMICIN; KANAMYCIN; MACROLIDE; MEROPENEM; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; TELITHROMYCIN; TETRACYCLINE DERIVATIVE; TOBRAMYCIN;

AGAR DILUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BROTH DILUTION; CAMPYLOBACTER; CAMPYLOBACTER COLI; CAMPYLOBACTER FETUS; CAMPYLOBACTER JEJUNI; CAMPYLOBACTER LARI; CAMPYLOBACTERIOSIS; DISK DIFFUSION; DNA SEQUENCE; EPSILOMETER; EPSILOMETER TEST; FLUORESCENCE IN SITU HYBRIDIZATION; FOOD POISONING; FOOD SAFETY; GENE MUTATION; GENOTYPING TECHNIQUE; LABORATORY DEVICE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW;

ANIMALIA; CAMPYLOBACTER; CAMPYLOBACTER JEJUNI;

ANTIMICROBIAL RESISTANCE; CAMPYLOBACTER; MOLECULAR; SUSCEPTIBILITY TESTING; TREND;

ANIMALS; ANTI-BACTERIAL AGENTS; CAMPYLOBACTER; DRUG RESISTANCE, BACTERIAL; FOOD MICROBIOLOGY; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR DIAGNOSTIC TECHNIQUES;

EID: 84884149199     PISSN: 01677012     EISSN: 18728359     Source Type: Journal    
DOI: 10.1016/j.mimet.2013.06.021     Document Type: Review

References (104)

1. Aarestrup F.M., McDermott P.F., Wegener H.C. Transmission of antibiotic resistance from food animals to humans. Campylobacter 2008, 645-665. ASM press, Washington, D. C. I. Nachamkin, C.M. Szymanski, M.J. Blaser (Eds.).
2. Agunos A., Leger D., Avery B.P., Parmley E.J., Deckert A., Carson C.A., Dutil L. Ciprofloxacin-resistant Campylobacter spp. in retail chicken, western Canada. Emerg. Infect. Dis. 2013, 19:1121-1124.
3. Alfredson D.A., Korolik V. Antibiotic resistance and resistance mechanisms in Campylobacter jejuni and Campylobacter coli. FEMS Microbiol. Lett. 2007, 277:123-132.
4. Alfredson D.A., Akhurst R.J., Korolik V. Antimicrobial resistance and genomic screening of clinical isolates of thermophilic Campylobacter spp. from south-east Queensland, Australia. J. Appl. Microbiol. 2003, 94:495-500.
5. Alonso R., Mateo E., Girbau C., Churruca E., Martinez I., Fernandez-Astorga A. PCR-restriction fragment length polymorphism assay for detection of gyrA mutations associated with fluoroquinolone resistance in Campylobacter coli. Antimicrob. Agents Chemother. 2004, 48:4886-4888.
6. Alonso R., Mateo E., Churruca E., Martinez I., Girbau C., Fernandez-Astorga A. MAMA-PCR assay for the detection of point mutations associated with high-level erythromycin resistance in Campylobacter jejuni and Campylobacter coli strains. J. Microbiol. Methods 2005, 63:99-103.
7. Aminov R.I., Garrigues-Jeanjean N., Mackie R.I. Molecular ecology of tetracycline resistance: development and validation of primers for detection of tetracycline resistance genes encoding ribosomal protection proteins. Appl. Environ. Microbiol. 2001, 67:22-32.
8. Baker C.N. The E-test and Campylobacter jejuni. Diagn. Microbiol. Infect. Dis. 1992, 15:469-472.
9. Barco L., Lettini A.A., Dalla Pozza M.C., Ramon E., Fasolato M., Ricci A. Fluoroquinolone resistance detection in Campylobacter coli and Campylobacter jejuni by Luminex xMAP technology. Foodborne Pathog. Dis. 2010, 7:1039-1045.
10. Blaser M.J., Engberg J. Clinical aspects of Campylobacter jejuni and Campylobacter coli infections. Campylobacter 2008, 99-121. ASM press, Washington, D. C. I. Nachamkin, C.M. Szymanski, M.J. Blaser (Eds.).
11. BSAC BSAC methods for antimicrobial susceptibility testing, version 11.1 May 2012 (Accessed December 20, 2012). http://bsac.org.uk/wp-content/uploads/2012/02/Version-11.1-2012-Final pdf.
12. Carattoli A., Dionisi A., Luzzi I. Use of a LightCycler gyrA mutation assay for identification of ciprofloxacin-resistant Campylobacter coli. FEMS Microbiol. Lett. 2002, 214:87-93.
13. CA-SFM Recommendations 2010 (Accessed December 20, 2012). http://nosobase.chu-lyon.fr/recommandations/sfm/2010_antibiotiques_casfm .pdf.
14. CDC Incidence and trends of infection with pathogens transmitted commonly through food - foodborne diseases active surveillance network, 10 U.S. sites, 1996-2012. MMWR Morb. Mortal. Wkly Rep. 2013, 62:283-287.
15. CLSI Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals; Approved Standard-Third Edition (M31-A3) 2008, Wayne, PA.
16. CLSI Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; Approved Guideline-Second Edition (M45-A2) 2010, Wayne, PA.
17. CLSI Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard-Ninth Edition (M07-A9) 2012, Wayne, PA.
18. CLSI Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard-Eleventh Edition (M02-A11) 2012, Wayne, PA.
19. CLSI Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement (M100-S22) 2012, Wayne, PA.
20. Corcoran D., Quinn T., Cotter L., Fanning S. An investigation of the molecular mechanisms contributing to high-level erythromycin resistance in Campylobacter. Int. J. Antimicrob. Agents 2006, 27:40-45.
21. Danish Ministry of Food Agriculture, Fisheries/Danish Ministry of Health The Danish Integrated Antimicrobial Resistance Monitoring and Research Program (Accessed January 15, 2013). http://www.danmap.org/.
22. Dunne W.M., Westblade L.F., Ford B. Next-generation and whole-genome sequencing in the diagnostic clinical microbiology laboratory. Clin. Microbiol. Infect. 2012, 31:1719-1726.
23. EFSA Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union. Clin. Microbiol. Infect. 2008, 14:522-533.
24. EFSA/ECDC The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in the European Union in 2009. EFSA J. 2011, 9:2154. (2321 pp.).
25. EFSA/ECDC The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2010. EFSA J. 2012, 10:2598. (2233 pp.).
26. EFSA/ECDC The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2011. EFSA J. 2013, 11:3196. (3359 pp.).
27. Engberg J., Andersen S., Skov R., Aarestrup F.M., Gerner-Smidt P. Comparison of two agar dilution methods and three agar diffusion methods, including the Etest, for antibiotic susceptibility testing of thermophilic Campylobacter species. Clin. Microbiol. Infect. 1999, 5:580-584.
28. EUCAST Clinical breakpoints, epidemiological cut-off (ECOFF) values and EUCAST disk diffusion methodology for Campylobacter jejuni and Campylobacter coli (Accessed December 20, 2012). http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Consultation /Campylobacter_wide_consultation_August_2012.pdf.
29. EUCAST MIC determination of non-fastidious and fastidious organisms (Accessed December 20, 2012). http://www.eucast.org/antimicrobial_susceptibility_testing/mic_determina tion/.
30. EUCAST Breakpoint tables for interpretation of MICs and zone diameters, version 3.0 (Accessed January 2, 2013). http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Disk_test_do cuments/EUCAST_Breakpoint_table_v_3.0.pdf.
31. EUCAST Routine internal quality control as recommended by EUCAST, version 3.0 (Accessed January 2, 2013). http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Disk_test_do cuments/EUCAST_Routine_QC_tables_3.0.pdf.
32. FDA Campylobacter jejuni. Bad Bug Book 2nd Edition: Foodborne Pathogenic Microorganisms and Natural Toxins Handbook 2012, (Washington, DC).
33. FDA/CDC/USDA NARMS retail meat annual report, 2011 (Accessed February 28, 2013). http://www.fda.gov/AnimalVeterinary/SafetyHealth/AntimicrobialResistance /NationalAntimicrobialResistanceMonitoringSystem/ucm334828.htm.
34. Fernandez H., Mansilla M., Gonzalez V. Antimicrobial susceptibility of Campylobacter jejuni subsp. jejuni assessed by E-test and double dilution agar method in Southern Chile. Mem. Inst. Oswaldo Cruz 2000, 95:247-249.
35. Fitzgerald C., Whichard J., Nachamkin I. Diagnosis and antimicrobial susceptibility of Campylobacter species. Campylobacter 2008, 227-243. ASM press, Washington, D. C. I. Nachamkin, C.M. Szymanski, M.J. Blaser (Eds.).
36. Fritsche T.R., McDermott P.F., Shryock T.R., Walker R.D., Morishita T.Y. Agar dilution and disk diffusion susceptibility testing of Campylobacter spp. J. Clin. Microbiol. 2007, 45:2758-2759. (author reply 2759).
37. Gaudreau C. Disk diffusion method for erythromycin and ciprofloxacin susceptibility testing of Campylobacter jejuni and Campylobacter coli. J. Clin. Microbiol. 2013, 51:380.
38. Gaudreau C., Gilbert H. Comparison of disc diffusion and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni subsp. jejuni and Campylobacter coli. J. Antimicrob. Chemother. 1997, 39:707-712.
39. Gaudreau C., Girouard Y., Ringuette L., Tsimiklis C. Comparison of disk diffusion and agar dilution methods for erythromycin and ciprofloxacin susceptibility testing of Campylobacter jejuni subsp. jejuni. Antimicrob. Agents Chemother. 2007, 51:1524-1526.
40. Gaudreau C., Girouard Y., Gilbert H., Gagnon J., Bekal S. Comparison of disk diffusion and agar dilution methods for erythromycin, ciprofloxacin, and tetracycline susceptibility testing of Campylobacter coli and for tetracycline susceptibility testing of Campylobacter jejuni subsp. jejuni. Antimicrob. Agents Chemother. 2008, 52:4475-4477.
41. Ge B., Bodeis S., Walker R.D., White D.G., Zhao S., McDermott P.F., Meng J. Comparison of the Etest and agar dilution for in vitro antimicrobial susceptibility testing of Campylobacter. J. Antimicrob. Chemother. 2002, 50:487-494.
42. Ge B., White D.G., McDermott P.F., Girard W., Zhao S., Hubert S., Meng J. Antimicrobial-resistant Campylobacter species from retail raw meats. Appl. Environ. Microbiol. 2003, 69:3005-3007.
43. Ge B., McDermott P.F., White D.G., Meng J. Role of efflux pumps and topoisomerase mutations in fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob. Agents Chemother. 2005, 49:3347-3354.
44. Gibreel A., Taylor D.E. Macrolide resistance in Campylobacter jejuni and Campylobacter coli. J. Antimicrob. Chemother. 2006, 58:243-255.
45. Gibreel A., Kos V.N., Keelan M., Trieber C.A., Levesque S., Michaud S., Taylor D.E. Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype. Antimicrob. Agents Chemother. 2005, 49:2753-2759.
46. Gibreel A., Wetsch N.M., Taylor D.E. Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni. Antimicrob. Agents Chemother. 2007, 51:3212-3216.
47. Gilbert J.M., White D.G., McDermott P.F. The U.S. national antimicrobial resistance monitoring system. Future Microbiol. 2007, 2:493-500.
48. Griggs D.J., Johnson M.M., Frost J.A., Humphrey T., Jorgensen F., Piddock L.J. Incidence and mechanism of ciprofloxacin resistance in Campylobacter spp. isolated from commercial poultry flocks in the United Kingdom before, during, and after fluoroquinolone treatment. Antimicrob. Agents Chemother. 2005, 49:699-707.
49. Guerrant R.L., Van Gilder T., Steiner T.S., Thielman N.M., Slutsker L., Tauxe R.V., Hennessy T., Griffin P.M., DuPont H., Sack R.B., Tarr P., Neill M., Nachamkin I., Reller L.B., Osterholm M.T., Bennish M.L., Pickering L.K. Practice guidelines for the management of infectious diarrhea. Clin. Infect. Dis. 2001, 32:331-351.
50. Haanpera M., Huovinen P., Jalava J. Detection and quantification of macrolide resistance mutations at positions 2058 and 2059 of the 23S rRNA gene by pyrosequencing. Antimicrob. Agents Chemother. 2005, 49:457-460.
51. Haas M., Essig A., Bartelt E., Poppert S. Detection of resistance to macrolides in thermotolerant Campylobacter species by fluorescence in situ hybridization. J. Clin. Microbiol. 2008, 46:3842-3844.
52. Halbert L.W., Kaneene J.B., Mansfield L.S., Ruegg P.L., Warnick L.D., Wells S.J., Fossler C.P., Campbell A.M., Geiger-Zwald A.M. Comparison of automated microbroth dilution and agar dilution for antimicrobial susceptibility of Campylobacter jejuni isolated from dairy sources. J. Antimicrob. Chemother. 2005, 56:686-691.
53. Hao H., Dai M., Wang Y., Chen D., Yuan Z. Quantification of mutated alleles of 23S rRNA in macrolide-resistant Campylobacter by TaqMan real-time polymerase chain reaction. Foodborne Pathog. Dis. 2010, 7:43-49.
54. Howe R.A., Andrews J.M. BSAC standardized disc susceptibility testing method (version 11). J. Antimicrob. Chemother. 2012, 67:2783-2784.
55. Huang M.B., Baker C.N., Banerjee S., Tenover F.C. Accuracy of the E test for determining antimicrobial susceptibilities of staphylococci, enterococci, Campylobacter jejuni, and Gram-negative bacteria resistant to antimicrobial agents. J. Clin. Microbiol. 1992, 30:3243-3248.
56. ISO Clinical laboratory testing and in vitro diagnostic test systems - susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices - part 1: reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases (ISO 20776-1), Switzerland 2006.
57. Jacobs B.C., van Belkum A., Endtz H.P. Guillain-Barre syndrome and Campylobacter infection. Campylobacter 2008, 245-261. ASM press, Washington, D. C. I. Nachamkin, C.M. Szymanski, M.J. Blaser (Eds.).
58. Jorgensen J.H., Ferraro M.J. Antimicrobial susceptibility testing: a review of general principles and contemporary practices. Clin. Infect. Dis. 2009, 49:1749-1755.
59. Kahlmeter G. EUCAST in 2012: aggregate MIC distributions and ECOFFs/Campylobacter spp. and AST (Accessed December 10, 2012). http://www.fda.gov/AnimalVeterinary/SafetyHealth/AntimicrobialResistance /NationalAntimicrobialResistanceMonitoringSystem/ucm334828.htm.
60. Lehtopolku M., Kotilainen P., Puukka P., Nakari U.M., Siitonen A., Eerola E., Huovinen P., Hakanen A.J. Inaccuracy of the disk diffusion method compared with the agar dilution method for susceptibility testing of Campylobacter spp. J. Clin. Microbiol. 2012, 50:52-56.
61. Lehtopolku M., Kotilainen P., Puukka P., Nakari U.M., Siitonen A., Eerola E., Huovinen P., Hakanen A.J. Reply to "Disk diffusion method for erythromycin and ciprofloxacin susceptibility testing of Campylobacter jejuni and Campylobacter coli". J. Clin. Microbiol. 2013, 51:381.
62. Lin J., Michel L.O., Zhang Q. CmeABC functions as a multidrug efflux system in Campylobacter jejuni. Antimicrob. Agents Chemother. 2002, 46:2124-2131.
63. Luangtongkum T., Morishita T.Y., El-Tayeb A.B., Ison A.J., Zhang Q. Comparison of antimicrobial susceptibility testing of Campylobacter spp. by the agar dilution and the agar disk diffusion methods. J. Clin. Microbiol. 2007, 45:590-594.
64. Luangtongkum T., Jeon B., Han J., Plummer P., Logue C.M., Zhang Q. Antibiotic resistance in Campylobacter: emergence, transmission and persistence. Future Microbiol. 2009, 4:189-200.
65. Luber P., Bartelt E., Genschow E., Wagner J., Hahn H. Comparison of broth microdilution, E Test, and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni and Campylobacter coli. J. Clin. Microbiol. 2003, 41:1062-1068.
66. Luo N., Sahin O., Lin J., Michel L.O., Zhang Q. In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump. Antimicrob. Agents Chemother. 2003, 47:390-394.
67. McDermott P.F., Bodeis S.M., Aarestrup F.M., Brown S., Traczewski M., Fedorka-Cray P., Wallace M., Critchley I.A., Thornsberry C., Graff S., Flamm R., Beyer J., Shortridge D., Piddock L.J., Ricci V., Johnson M.M., Jones R.N., Reller B., Mirrett S., Aldrobi J., Rennie R., Brosnikoff C., Turnbull L., Stein G., Schooley S., Hanson R.A., Walker R.D. Development of a standardized susceptibility test for Campylobacter with quality-control ranges for ciprofloxacin, doxycycline, erythromycin, gentamicin, and meropenem. Microb. Drug Resist. 2004, 10:124-131.
68. McDermott P.F., Bodeis-Jones S.M., Fritsche T.R., Jones R.N., Walker R.D. Broth microdilution susceptibility testing of Campylobacter jejuni and the determination of quality control ranges for fourteen antimicrobial agents. J. Clin. Microbiol. 2005, 43:6136-6138.
69. McGill K., Kelly L., Madden R.H., Moran L., Carroll C., O'Leary A., Moore J.E., McNamara E., O'Mahony M., Fanning S., Whyte P. Comparison of disc diffusion and epsilometer (E-test) testing techniques to determine antimicrobial susceptibility of Campylobacter isolates of food and human clinical origin. J. Microbiol. Methods 2009, 79:238-241.
70. Moore J.E., Barton M.D., Blair I.S., Corcoran D., Dooley J.S., Fanning S., Kempf I., Lastovica A.J., Lowery C.J., Matsuda M., McDowell D.A., McMahon A., Millar B.C., Rao J.R., Rooney P.J., Seal B.S., Snelling W.J., Tolba O. The epidemiology of antibiotic resistance in Campylobacter. Microbes Infect. 2006, 8:1955-1966.
71. Mughini Gras L., Smid J.H., Wagenaar J.A., de Boer A.G., Havelaar A.H., Friesema I.H., French N.P., Busani L., van Pelt W. Risk factors for campylobacteriosis of chicken, ruminant, and environmental origin: a combined case-control and source attribution analysis. PLoS One 2012, 7:e42599.
72. Nachamkin I., Engberg J., Aarestrup F.M. Diagnosis and antimicrobial susceptibility of Campylobacter spp. Campylobacter 2000, 45-66. ASM press, Washington, D. C. I. Nachamkin, M.J. Blaser (Eds.).
73. Neimann J., Engberg J., Molbak K., Wegener H.C. A case-control study of risk factors for sporadic Campylobacter infections in Denmark. Epidemiol. Infect. 2003, 130:353-366.
74. NETHMAP, MARAN NETHMAP 2012 (consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands) and MARAN 2012 (monitoring of antimicrobial resistance and antibiotic usage in animals in the Netherlands) (Accessed December 20, 2012). http://www.uu.nl/SiteCollectionImages/Fac_DGK/Nieuwsplaatjes/Nieuws/2012 /NethmapMaran_Web.pdf.
75. Niwa H., Chuma T., Okamoto K., Itoh K. Rapid detection of mutations associated with resistance to erythromycin in Campylobacter jejuni/coli by PCR and line probe assay. Int. J. Antimicrob. Agents 2001, 18:359-364.
76. Niwa H., Chuma T., Okamoto K., Itoh K. Simultaneous detection of mutations associated with resistance to macrolides and quinolones in Campylobacter jejuni and C. coli using a PCR-line probe assay. Int. J. Antimicrob. Agents 2003, 22:374-379.
77. NORM/NORM-VET NORM/NORM-VET 2011 - usage of antimicrobial agents and occurrence of antimicrobial resistance in Norway (Accessed December 20, 2012). http://www.vetinst.no/eng/content/download/9684/118431/file/NORM_NORM-VE T_2011.pdf.
78. Okada H., Kitazawa T., Harada S., Itoyama S., Hatakeyama S., Ota Y., Koike K. Combined treatment with oral kanamycin and parenteral antibiotics for a case of persistent bacteremia and intestinal carriage with Campylobacter coli. Intern. Med. 2008, 47:1363-1366.
79. Oncul O., Zarakolu P., Gur D. Antimicrobial susceptibility testing of Campylobacter jejuni: a comparison between Etest and agar dilution method. Diagn. Microbiol. Infect. Dis. 2003, 45:69-71.
80. Pacanowski J., Lalande V., Lacombe K., Boudraa C., Lesprit P., Legrand P., Trystram D., Kassis N., Arlet G., Mainardi J.L., Doucet-Populaire F., Girard P.M., Meynard J.L. Campylobacter bacteremia: clinical features and factors associated with fatal outcome. Clin. Infect. Dis. 2008, 47:790-796.
81. Padungtod P., Kaneene J.B., Wilson D.L., Bell J., Linz J.E. Determination of ciprofloxacin and nalidixic acid resistance in Campylobacter jejuni with a fluorogenic polymerase chain reaction assay. J. Food Prot. 2003, 66:319-323.
82. Payot S., Avrain L., Magras C., Praud K., Cloeckaert A., Chaslus-Dancla E. Relative contribution of target gene mutation and efflux to fluoroquinolone and erythromycin resistance, in French poultry and pig isolates of Campylobacter coli. Int. J. Antimicrob. Agents 2004, 23:468-472.
83. Payot S., Bolla J.M., Corcoran D., Fanning S., Megraud F., Zhang Q. Mechanisms of fluoroquinolone and macrolide resistance in Campylobacter spp. Microbes Infect. 2006, 8:1967-1971.
84. Public Health Agency of Canada CIPARS antimicrobial resistance short report 2011 (Accessed December 20, 2012). http://www.phac-aspc.gc.ca/cipars-picra/pubs-eng.php#sr.
85. Public Health Agency of Canada Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) (Accessed January 15, 2013). http://www.phac-aspc.gc.ca/cipars-picra/index-eng.php.
86. Ren G.W., Wang Y., Shen Z., Chen X., Shen J., Wu C. Rapid detection of point mutations in domain V of the 23S rRNA gene in erythromycin-resistant Campylobacter isolates by pyrosequencing. Foodborne Pathog. Dis. 2011, 8:375-379.
87. Said M.M., El-Mohamady H., El-Beih F.M., Rockabrand D.M., Ismail T.F., Monteville M.R., Ahmed S.F., Klena J.D., Salama M.S. Detection of gyrA mutation among clinical isolates of Campylobacter jejuni isolated in Egypt by MAMA-PCR. J. Infect. Dev. Ctries. 2010, 4:546-554.
88. Skirrow M.B., Blaser M.J. Clinical aspects of Campylobacter infection. Campylobacter 2000, 69-88. ASM press, Washington, D. C. 2nd ed. I. Nachamkin, M.J. Blaser (Eds.).
89. Smith M.S., Yang R.K., Knapp C.W., Niu Y., Peak N., Hanfelt M.M., Galland J.C., Graham D.W. Quantification of tetracycline resistance genes in feedlot lagoons by real-time PCR. Appl. Environ. Microbiol. 2004, 70:7372-7377.
90. Stafford R.J., Schluter P., Kirk M., Wilson A., Unicomb L., Ashbolt R., Gregory J. A multi-centre prospective case-control study of Campylobacter infection in persons aged 5years and older in Australia. Epidemiol. Infect. 2007, 135:978-988.
91. Swedish Institute for Communicable Disease Control SWEDRES 2011-a report on Swedish antibiotic utilisation and resistance in human medicine (Accessed December 20, 2012). http://www.smittskyddsinstitutet.se/upload/Publikationer/SWEDRES-SVARM-2 011_2012-15-3.pdf.
92. Taylor D.E., Hiratsuka K., Ray H., Manavathu E.K. Characterization and expression of a cloned tetracycline resistance determinant from Campylobacter jejuni plasmid pUA466. J. Bacteriol. 1987, 169:2984-2989.
93. Ternhag A., Asikainen T., Giesecke J., Ekdahl K. A meta-analysis on the effects of antibiotic treatment on duration of symptoms caused by infection with Campylobacter species. Clin. Infect. Dis. 2007, 44:696-700.
94. Vacher S., Menard A., Bernard E., Megraud F. PCR-restriction fragment length polymorphism analysis for detection of point mutations associated with macrolide resistance in Campylobacter spp. Antimicrob. Agents Chemother. 2003, 47:1125-1128.
95. Vacher S., Menard A., Bernard E., Santos A., Megraud F. Detection of mutations associated with macrolide resistance in thermophilic Campylobacter spp. by real-time PCR. Microb. Drug Resist. 2005, 11:40-47.
96. Valdivieso-Garcia A., Imgrund R., Deckert A., Varughese B.M., Harris K., Bunimov N., Reid-Smith R., McEwen S. Cost analysis and antimicrobial susceptibility testing comparing the E test and the agar dilution method in Campylobacter jejuni and Campylobacter coli. Diagn. Microbiol. Infect. Dis. 2009, 65:168-174.
97. van der Beek M.T., Claas E.C., Mevius D.J., van Pelt W., Wagenaar J.A., Kuijper E.J. Inaccuracy of routine susceptibility tests for detection of erythromycin resistance of Campylobacter jejuni and Campylobacter coli. Clin. Microbiol. Infect. 2010, 16:51-56.
98. Varela N.P., Friendship R., Dewey C., Valdivieso A. Comparison of agar dilution and E-test for antimicrobial susceptibility testing of Campylobacter coli isolates recovered from 80 Ontario swine farms. Can. J. Vet. Res. 2008, 72:168-174.
99. Yu Z., Michel F.C., Hansen G., Wittum T., Morrison M. Development and application of real-time PCR assays for quantification of genes encoding tetracycline resistance. Appl. Environ. Microbiol. 2005, 71:6926-6933.
100. Zaidi M.B., McDermott P.F., Campos F.D., Chim R., Leon M., Vazquez G., Figueroa G., Lopez E., Contreras J., Estrada-Garcia T. Antimicrobial-resistant Campylobacter in the food chain in Mexico. Foodborne Pathog. Dis. 2012, 9:841-847.
101. Zankari E., Hasman H., Cosentino S., Vestergaard M., Rasmussen S., Lund O., Aarestrup F.M., Larsen M.V. Identification of acquired antimicrobial resistance genes. J. Antimicrob. Chemother. 2012, 67:2640-2644.
102. Zhang Q., Plummer P.J. Mechanisms of antibiotic resistance in Campylobacter. Campylobacter 2008, 263-276. ASM press, Washington, D. C. I. Nachamkin, C.M. Szymanski, M.J. Blaser (Eds.).
103. Zirnstein G., Li Y., Swaminathan B., Angulo F. Ciprofloxacin resistance in Campylobacter jejuni isolates: detection of gyrA resistance mutations by mismatch amplification mutation assay PCR and DNA sequence analysis. J. Clin. Microbiol. 1999, 37:3276-3280.
104. Zirnstein G., Helsel L., Li Y., Swaminathan B., Besser J. Characterization of gyrA mutations associated with fluoroquinolone resistance in Campylobacter coli by DNA sequence analysis and MAMA PCR. FEMS Microbiol. Lett. 2000, 190:1-7.